Literature DB >> 22180149

Homozygous mutation in MERTK causes severe autosomal recessive retinitis pigmentosa.

Mohamed Ksantini1, Estèle Lafont, Béatrice Bocquet, Isabelle Meunier, Christian P Hamel.   

Abstract

PURPOSE: Gene identification in retinitis pigmentosa is a prerequisite to future therapies. Accordingly, autosomal recessive retinitis pigmentosa families were genotyped to search for causative mutations.
METHODS: Members of a consanguineous Moroccan family had standard ophthalmologic examination, optical coherence tomography-3 scan, autofluorescence testing, and electroretinogram. Their DNA was genotyped with the 250K SNP microchip (Affymetrix) and homozygosity mapping was done. MERTK exons were polymerase chain reaction amplified and sequenced.
RESULTS: Two sisters and one brother out of 6 siblings had rod cone dystrophy type of retinitis pigmentosa. Salient features were night blindness starting in early infancy, dot-like whitish deposits in fovea and macula with corresponding autofluorescent dots in youngest patients, decreased visual acuity, and cone responses higher than rod responses at electroretinogram. The patients were homozygous in regions from chromosomes 2 and 8, but only that of chromosome 2 was inherited from a common ancestor. Sequencing of the MERTK gene belonging to the chromosome 2 region showed that the 3 affected patients carried a novel homozygous mutation in exon 17, c.2323C>T, leading to p.Arg775X, while their unaffected brothers and sister, parents, and paternal grandfather were heterozygous.
CONCLUSIONS: MERTK mutations lead to severe retinitis pigmentosa with discrete dot-like autofluorescent deposits at early stages, which are a hallmark of this MERTK-specific dystrophy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22180149     DOI: 10.5301/ejo.5000096

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  19 in total

Review 1.  Gene therapy and genome surgery in the retina.

Authors:  James E DiCarlo; Vinit B Mahajan; Stephen H Tsang
Journal:  J Clin Invest       Date:  2018-06-01       Impact factor: 14.808

Review 2.  TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.

Authors:  Yemsratch T Akalu; Carla V Rothlin; Sourav Ghosh
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

3.  Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa.

Authors:  Thomas J Conlon; Wen-Tao Deng; Kirsten Erger; Travis Cossette; Ji-jing Pang; Renee Ryals; Nathalie Clément; Brian Cleaver; Issam McDoom; Shannon E Boye; Marc C Peden; Mark B Sherwood; Corinne R Abernathy; Fowzan S Alkuraya; Sanford L Boye; William W Hauswirth
Journal:  Hum Gene Ther Clin Dev       Date:  2013-04-03       Impact factor: 5.032

4.  Retinitis pigmentosa, cutis laxa, and pseudoxanthoma elasticum-like skin manifestations associated with GGCX mutations.

Authors:  Ariana Kariminejad; Bita Bozorgmehr; Abdolhamid Najafi; Atefeh Khoshaeen; Maryam Ghalandari; Hossein Najmabadi; Mohamad H Kariminejad; Olivier M Vanakker; Mohammad J Hosen; Fransiska Malfait; Daniela Quaglino; Ralph J Florijn; Arthur A B Bergen; Raoul C Hennekam
Journal:  J Invest Dermatol       Date:  2014-04-16       Impact factor: 8.551

5.  The genetics of rod-cone dystrophy in Arab countries: a systematic review.

Authors:  Hawraa Joumaa; Zamzam Mrad; Lama Jaffal; Christina Zeitz; Isabelle Audo; Said El Shamieh
Journal:  Eur J Hum Genet       Date:  2020-11-13       Impact factor: 5.351

6.  A non-stop S-antigen gene mutation is associated with late onset hereditary retinal degeneration in dogs.

Authors:  Orly Goldstein; Julie Ann Jordan; Gustavo D Aguirre; Gregory M Acland
Journal:  Mol Vis       Date:  2013-08-27       Impact factor: 2.367

7.  Homozygosity mapping in autosomal recessive retinitis pigmentosa families detects novel mutations.

Authors:  Béatrice Bocquet; Nour Al Dain Marzouka; Maxime Hebrard; Gaël Manes; Audrey Sénéchal; Isabelle Meunier; Christian P Hamel
Journal:  Mol Vis       Date:  2013-12-08       Impact factor: 2.367

8.  Increased expression of MERTK is associated with a unique form of canine retinopathy.

Authors:  Saija J Ahonen; Meharji Arumilli; Eija Seppälä; Osmo Hakosalo; Maria K Kaukonen; András M Komáromy; Hannes Lohi
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

9.  Human iPSC derived disease model of MERTK-associated retinitis pigmentosa.

Authors:  Dunja Lukovic; Ana Artero Castro; Ana Belen Garcia Delgado; María de los Angeles Martín Bernal; Noelia Luna Pelaez; Andrea Díez Lloret; Rocío Perez Espejo; Kunka Kamenarova; Laura Fernández Sánchez; Nicolás Cuenca; Marta Cortón; Almudena Avila Fernandez; Anni Sorkio; Heli Skottman; Carmen Ayuso; Slaven Erceg; Shomi S Bhattacharya
Journal:  Sci Rep       Date:  2015-08-11       Impact factor: 4.379

10.  A novel start codon mutation of the MERTK gene in a patient with retinitis pigmentosa.

Authors:  Worapoj Jinda; Naravat Poungvarin; Todd D Taylor; Yutaka Suzuki; Wanna Thongnoppakhun; Chanin Limwongse; Patcharee Lertrit; Prapat Suriyaphol; La-Ongsri Atchaneeyasakul
Journal:  Mol Vis       Date:  2016-04-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.